International Journal of Pharmaceutical Chemistry and Analysis


Brief update on management of hypertension in diabetic patients


Full Text PDF Share on Facebook Share on Twitter


Author Details: Saraswati Prasad Mishra, Anil Kumar Sahu, Pankaj Kashyap, Deepak Dash, Koushlesh Mishra, Rupesh Bhoi

Volume : 4

Issue : 2

Online ISSN : 2394-2797

Print ISSN : 2394-2789

Article First Page : 27

Article End Page : 29


Abstract

Nowadays there is increased prevalence of co-morbidity of hypertension and diabetes. Hypertension has become such a bigger health problem as it does not show any manifestation of it until it gets seriously complicated. High blood pressure is the major cause of premature deaths which comes around 7.6 million (about 13.5% of the global total) worldwide. Non-insulin dependent diabetes mellitus (NIDDM) is a global pandemic. By 2025 it is been projected that around 300 million people will have NIDDM worldwide. WHO projects that diabetes will be the 7th leading cause of death in 2030. Diabetes and Hypertension often termed as co-morbid disease as there is greater tendency of both the complication occurring together. The prevalence of hypertension among T2DM patients varies across countries and is reported to range from 20.6% to 78.4% in the Southeast Asian region, and 9.7% to 70.4% in the African region, in India it is 6.4% to 55%. To reduce the complications of diabetes in co-morbidity, hypertension should be in the range of 130/90 mmHg for that apart from allopathic system of therapy ayurvedic and unani system of therapy and certain lifestyle changes can be undertaken as these systems do not have drawbacks such as side effect, long duration treatment, and high cost therapy.

Keywords:
Hypertension, Diabetes, Co- morbidity, Pharmacotherapy, Ayurveda, Unani